Malignant rhabdoid tumour classification: Difference between revisions

	Malignant rhabdoid tumour Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Malignant Rhabdoid Tumour from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Malignant rhabdoid tumour classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Malignant rhabdoid tumour classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Malignant rhabdoid tumour classification
CDC on Malignant rhabdoid tumour classification
Malignant rhabdoid tumour classification in the news
Blogs on Malignant rhabdoid tumour classification
Directions to Hospitals Treating Malignant rhabdoid tumour
Risk calculators and risk factors for Malignant rhabdoid tumour classification

Revision as of 15:30, 11 September 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 3: / Line 3: @@
 ==Overview==
-'''Malignant rhabdoid tumor''' was first described as a variant of [[Wilms' tumor]] of the kidney in 1978.<ref name="pmid206343">{{cite journal |author=Beckwith JB, Palmer NF |title=Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study |journal=Cancer |volume=41 |issue=5 |pages=1937–48 |year=1978 |pmid=206343 |doi=}}</ref>
 ==References==